Sotera Health Company
Cash Flow Statement
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Operating Activities | |||||||
| Net Income | $77.9M | $44.4M | $51.4M | $-233.6M | $116.9M | $-38.6M | $-20.9M |
| Depreciation & Amortization | $94.9M | $84.3M | $76.6M | $64.3M | $64.2M | $63.3M | $66.7M |
| Depreciation | $94.9M | $84.3M | $76.6M | $64.0M | $64.2M | $63.3M | $66.7M |
| Amortization | $41.8M | $79.4M | $81.3M | $81.6M | $86.7M | $80.3M | $80.0M |
| Stock-Based Compensation | $30.9M | $36.8M | $32.2M | $21.2M | $13.9M | $11.0M | $6.9M |
| Net Cash from Operating Activities | $287.2M | $224.2M | $-147.7M | $278.0M | $281.5M | $120.6M | $149.0M |
| Investing Activities | |||||||
| Capital Expenditures | $138.0M | $179.1M | $215.0M | $182.4M | $102.2M | $53.5M | $57.3M |
| Business Acquisitions | — | — | $0 | $0 | $13.5M | $0 | $0 |
| Net Cash from Investing Activities | $-135.1M | $-179.0M | $-214.9M | $-181.9M | $-159.8M | $-158.7M | $-57.3M |
| Financing Activities | |||||||
| Dividends Paid | — | — | — | — | $0 | $0 | $691.2M |
| Stock Repurchases | — | — | — | $0 | $0 | $34.0M | $0 |
| Net Cash from Financing Activities | $-100.5M | $-50.6M | $266.0M | $197.8M | $-117.3M | $73.4M | $-126.0M |
| Net Change in Cash | $67.6M | $-22.8M | $-94.6M | $289.4M | $4.5M | $39.4M | $-33.8M |
| Free Cash Flow | $149.2M | $45.1M | $-362.7M | $95.6M | $179.4M | $67.1M | $91.8M |